Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 7 results.
User Information
Export Records
  1. 1.   Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran
  2. Kumar, Parag; Gordon, Lori A.; Brooks, Kristina M.; George, Jomy M.; Kellogg, Anela; McManus, Maryellen; Alfaro, Raul M.; Nghiem, Khanh; Lozier, Jay; Hadigan, Colleen; Penzak, Scott R.
  3. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2017, NOV; 61(11):
  1. 2.   Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers.
  2. Gordon, Lori A; Kumar, Parag; Brooks, Kristina M; Kellogg, Anela; McManus, Maryellen; Alfaro, Raul M; Nghiem, Khanh; George, Jomy M; Lozier, Jay; Penzak, Scott R; Hadigan, Colleen
  3. Circulation. 2016, Dec 6; 134(23): 1909-1911.
  1. 3.   Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects
  2. Robertson, S. M.; Maldarelli, F.; Natarajan, V.; Formentini, E.; Alfaro, R. M.; Penzak, S. R.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2008 49(5): 513-519.
  1. 4.   Structural dynamics of the cooperative binding of organic molecules in the human cytochrome P450 3A4
  2. Fishelovitch, D.; Hazan, C.; Shaik, S.; Wolfson, H. J.; Nussinov, R.
  3. Journal of the American Chemical Society. 2007, Feb; 129(6): 1602-1611.
  1. 5.   Prednisolone pharmacokinetics in the presence and absence of Ritonavir after oral prednisone administration to healthy volunteers
  2. Penzak, S. R.; Fomnentini, E.; Alfaro, R. M.; Long, M.; Natarajan, V.; Kovacs, J.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 15; 40(5): 573-580.
  1. 6.   Suboptimal prescribing in elderly outpatients: Potentially harmful drug-drug and drug-disease combinations
  2. Zhan, C. L.; Correa-de-Araujo, R.; Bierman, A. S.; Sangl, J.; Miller, M. R.; Wickizer, S. W.; Stryer, D.
  3. Journal of the American Geriatrics Society. 2005, FEB; 53(2): 262-267.
  1. 7.   Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs
  2. Wei,Bih; Peer, Cody J; Richardson, William J; Hewitt, Stephen M; Figg, William D; Simpson, R Mark
  3. Frontiers in Veterinary Science. 2022 9: 1056408.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel